Proximal femur bone marrow blood perfusion indices are reduced in hypertensive rats: A dynamic contrast-enhanced MRI study

✍ Scribed by Ya-Feng Zhang; Yi-Xiang J. Wang; James F. Griffith; William K.M. Kwong; Heather T. Ma; Ling Qin; Timothy C.Y. Kwok

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 171 KB
• Volume: 30
• Category: Article
• ISSN: 1053-1807
• DOI: 10.1002/jmri.21954

✦ Synopsis

Abstract

Purpose:

To investigate the differences in proximal femoral bone marrow blood perfusion indices between hypertensive and normotensive rats using perfusion magnetic resonance imaging (MRI).

Materials and Methods:

Six‐month‐old male spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) were used (12 of each). Dynamic contrast‐enhanced MRI of the right hip was performed after bolus injection of Gd‐DOTA administered through a tail vein cannula. In all, 800 images were acquired at 0.6 sec/image. Regions of interest (ROIs) were drawn comprising the medullary component of proximal femoral shaft and femoral head. MRI maximum enhancement (E^max^) and enhancement slope (E^slope^) were analyzed.

Results:

The E^max^ and E^slope^ of proximal femoral shaft and femoral head of SHR were significantly lower than those of WKY (E^max^: 107.4 ± 18.2% vs. 130.6 ± 21.5%, P = 0.009, and 76.0 ± 12.5% vs. 97.9 ± 6.9%, P < 0.001, respectively; E^slope^: 3.01 ± 0.63%/sec vs. 3.75 ± 0.74%/sec, P = 0.016, and 1.95 ± 0.33%/sec vs. 2.28 ± 0.28%/sec, P = 0.012, respectively). The E^max^ and E^slope^ of femoral head were significantly lower than those of proximal femoral shaft in both SHR and WKY (P < 0.001). In both SHR and WKY, proximal femoral shaft and femoral head had a rather different contrast enhancement pattern.

Conclusion:

Proximal femoral shaft and femoral head bone marrow blood perfusion indices were significantly lower in hypertensive rats than in normotensive rats. Femoral head bone marrow was less perfused than proximal femoral shaft in both rats. J. Magn. Reson. Imaging 2009. © 2009 Wiley‐Liss, Inc.